Is Now the Right Time to Hold on to Charles River Stock?

Charles River Laboratories International, Inc.’s (CRL) leadership in outsourced drug discovery and safety testing services supports the growth in its DSA (Discovery and Safety Assessment) segment. Through targeted acquisitions and collaborations, the company enhances its offerings across the drug discovery and early-development continuum. Additionally, the RMS (Research Models and Services) segment sees broad-based growth in all geographic regions for small research models. Yet, the adverse macroeconomic im ...